Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 08 Sept 2025 for NFL Biosciences, €27k. Read the official filing
Filing timeline
BuySaleBruno Lafont
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
Bruno Lafont: trading record in brief
Bruno Lafont is a declared insider of NFL Biosciences (chief executive), with filings sourced from AMF. Over a trading history stretching from 24 April 2023 to 2 September 2025, the count stands at 7 filings.
The open-market record consists of 4 sales worth €337k, with no purchase. The rest of the record consists of 1 share grant and 2 option exercises. 2025 to date brings no purchases and 2 sales.
Most recently, on 8 September 2025, the filings show an open-market sale worth €27k in NFL Biosciences. Between a trade and the moment it shows up on AMF, the median delay is 4 days. The legal deadline for notifying a trade is three business days (MAR article 19). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.
Companies and markets linked to Bruno Lafont
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
18,000 shares@ €1.52255.9% of flowActionEuronext Growth ParisISIN FR0014003XT02025DD1056681
41,650 shares@ €1.188210.7% of flowActionEuronext Growth ParisISIN FR0014003XT02025DD1049758
250,000 shares@ €0.3016.2% of flowActionEuronext Growth ParisISIN FR0014003XT02025DD1032010
500,000 shares@ €0.1010.8% of flowActionEuronext Growth ParisISIN FR0014003XT02023DD918253
57,000 shares@ €2.653932.8% of flowActionEuronext Growth ParisISIN FR0014003XT02023DD918168
43,000 shares@ €2.523623.5% of flowActionEuronext Growth ParisISIN FR0014003XT02023DD918207
71,778 shares0ActionEuronext Growth ParisISIN FR0014003XT02023DD897035
7 of 7 declarations
